Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Muir-Torre syndrome]

R Yoshikawa1, J Utsunomiya

  • 1Second Department of Surgery, Hyogo College of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Muir-Torre syndrome (MTS) is a rare genetic disorder causing skin tumors and internal cancers. Early detection and lifelong surveillance are crucial for affected families to manage associated cancer risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression of Vincristin-induced Peripheral Neuropathy Related to Different Administration Methods.

Die Pharmazie·2022
Same author

Association between immune-related dermatologic adverse events and efficacy of pembrolizumab in non-small cell lung cancer patients.

Die Pharmazie·2021
Same author

Application of Perfusate With Human-Derived Oxygen Carrier Solution Under Subnormothermic Machine Perfusion for Donation After Cardiac Death Liver Grafts in Pigs.

Transplantation proceedings·2018
Same author

Ex Vivo Reperfusion Model to Evaluate Utility of Machine Preservation for Porcine Liver Donated After Cardiac Death.

Transplantation proceedings·2018
Same author

Optimum Perfusate Volume of Purified Subnormothermic Machine Perfusion for Porcine Liver Donated After Cardiac Death.

Transplantation proceedings·2018
Same author

Comparison between S+L- assay and LacZ marker rescue assay for detecting replication-competent gammaretroviruses.

Biologicals : journal of the International Association of Biological Standardization·2015
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Area of Science:

  • Dermatology
  • Oncology
  • Genetics

Context:

  • Muir-Torre syndrome (MTS) is an autosomal dominant genodermatosis.
  • Characterized by sebaceous gland tumors and internal malignancies.
  • Shares features with hereditary nonpolyposis colorectal carcinoma (HNPCC).

Purpose:

  • To define the characteristics and associated neoplasms of Muir-Torre syndrome.
  • To highlight the clinical and pathological similarities between MTS and HNPCC.
  • To emphasize the need for early cancer detection and lifelong surveillance in affected families.

Summary:

  • MTS involves sebaceous gland tumors (with or without keratoacanthoma) and internal cancers.
  • Colorectal (51%) and genitourinary (25%) neoplasms are most common.

Related Experiment Videos

  • Key similarities with HNPCC include right-sided colon cancers, extracolonic tumors, and prolonged survival post-surgery.

    • Impact:

    • Facilitates earlier diagnosis of Muir-Torre syndrome.
    • Improves understanding of cancer predisposition in MTS patients.
    • Guides clinical management through recommended lifelong surveillance protocols.